TROW
61
5
RF
66
2
F
60
2
UNH
63
4
VFC
57
4
IPG
61
5
ES
38
4
PRGO
43
4
IRM
50
3
NRG
40
-9
TXN
46
4
GM
72
3
PNR
71
2
DAL
83
4
MMM
37
5
GT
65
3
FOX
48
-3
PNC
67
3
ECL
59
5
HCP
70
2
TROW
61
5
RF
66
2
F
60
2
UNH
63
4
VFC
57
4
IPG
61
5
ES
38
4
PRGO
43
4
IRM
50
3
NRG
40
-9
TXN
46
4
GM
72
3
PNR
71
2
DAL
83
4
MMM
37
5
GT
65
3
FOX
48
-3
PNC
67
3
ECL
59
5
HCP
70
2
Financhill
Back

Applied Therapeutics Quote, Financials, Valuation and Earnings

Invest. Do Good. Get Rewarded. Just $0.26/Share!

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
72

APLT
Applied Therapeutics

Last Price:
10.19
Seasonality Move:
53.2%

7 Day Trial

ALL ACCESS PASS

$ 7

Trade on Tuesday. Profit on Friday. Rinse & Repeat

Get the full details now.

Applied Therapeutics Price Quote

$10.19
+0.60 (+6.26%)
(Updated: November 26, 2024 at 5:55 PM ET)

Applied Therapeutics Key Stats

Buy
72
Applied Therapeutics (APLT) is a Buy
Day range:
$9.24 - $9.93
52-week range:
$1.79 - $10.62
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
189.39%
Volume:
4M
Avg. volume:
1.8M
1-year change:
418.38%
Market cap:
$1.1B
Revenue:
$10M
EPS:
$-1.61

How Much Does Applied Therapeutics Make?

Is Applied Therapeutics Growing As A Company?

Data Unavailable

Applied Therapeutics Stock Price Performance

What Is Applied Therapeutics 52-Week High & Low?

Applied Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Applied Therapeutics?

Is Applied Therapeutics Cash Flow Positive?

  • What Is APLT Cash Flow From Operations?
    Cash flow from operations (TTM) is -$81.8M
  • What Is Applied Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $143.3M
  • What Is Applied Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $0

Applied Therapeutics Return On Invested Capital

  • Is Management Doing A Good Job?
    APLT return on invested capital is -790.52%
  • What Is Applied Therapeutics Return On Assets?
    ROA measures how assets are converting to revenues and is -192.86%
  • What Is APLT Return On Equity?
    ROE is a measure of profitability and is -797.82%

Applied Therapeutics Earnings Date & Stock Price

Applied Therapeutics Competitors

Applied Therapeutics Dividend Yield

Applied Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -195.49%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 5
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 14.67
Upside from Last Price: 52.94%

Major Shareholders

  • How many APLT shares are owned by institutional investors?
    157.3M APLT shares are owned by institutional investors
  • How many APLT shares are owned by insiders?
    8.3M APLT shares are owned by insiders